How Can Variable Patient Groups Be Addressed in CAR T?
https://vimeo.com/944065239 Can CAR T-cell therapy address variable patient groups? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses variances in different myeloma patient groups, the KarMMa-3 study,…
What Patient Types Are Good Candidates for CAR T-Cell Therapy?
What Patient Types Are Good Candidates for CAR T-Cell Therapy? from Patient Empowerment Network on Vimeo. For CAR T-cell therapy, what patient types are good candidates? Expert Dr. Krina Patel…
[ACT]IVATED CAR T-Cell Therapy Resource Guide en español
Descargar Guía Descargar Guía See More from [ACT]IVATED CAR T
[ACT]IVATED CAR T-Cell Therapy Resource Guide
Download Guide Download Guide See More from [ACT]IVATED CAR T
Can Race or Ethnicity Impact CAR T-Cell Therapy Response?
Can Race or Ethnicity Impact CAR T-Cell Therapy Response? from Patient Empowerment Network on Vimeo. Can CAR T-cell therapy response be impacted by patient race or ethnicity? Expert Dr. Sikander…
How Are Rural CAR T-Cell Therapy Barriers Being Addressed?
https://vimeo.com/926991929 How are barriers to CAR T-cell therapy care in rural areas being reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses positive patient care developments from COVID and how patients…
How Do Race and Ethnicity Impact CAR T Side Effects?
https://vimeo.com/926991984 How are CAR T side effects impacted by race and ethnicity? Expert Dr. Sikander Ailawadhi from Mayo Clinic shares some research study results about CAR T response rates and disease progression…
How Can Information Disparities on Emerging Therapies Be Addressed?
https://vimeo.com/926992036 How can gaps in information about emerging myeloma therapies be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses some demographic characteristics of information disparities and advice for myeloma experts and…
How Can Equitable CAR T-Cell Therapy Access Be Increased?
https://vimeo.com/926992122 How can CAR T-cell therapy access issues be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains some common access issues that can arise for patient CAR T care and some…
How Are Cultural and Language Barriers to CAR T Therapy Being Addressed?
https://vimeo.com/926992189 How are CAR T therapy barriers of cultural and language nature being addressed? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses research study results on access barriers and ways to create…
Roadblocks for Black and Latinx Patients From CAR T Trial Access
https://vimeo.com/926992230 What are CAR T-cell therapy roadblocks for Black and Latinx trial access? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses barriers that have been documented in clinical research and solutions and…
Reducing CAR T-Cell Therapy Barriers for Relapsed/Refractory Myeloma
https://vimeo.com/926992265 How can CAR T-cell therapy barriers for relapsed/refractory myeloma be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic shares his perspective about barriers to CAR T and advice for patients to…